EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, PRLD: Prelude Therapeutics Inc

03 Nov 25 15:59
LAST:

3.980

CHANGE:
 2.39		OPEN:
1.590		HIGH:
4.220		ASK:
0.000		VOLUME:
22.81M
CHG(%):
150.31		PREV:
1.590		LOW:
1.430		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Nov 251.5804.2201.4303.98034.55M
31 Oct 251.5601.6401.5101.590111.3K
30 Oct 251.5701.6101.4701.570141.4K
29 Oct 251.5701.6191.5001.580177.0K
28 Oct 251.7201.7201.5401.540125.5K
27 Oct 251.6601.7151.5701.710269.7K
24 Oct 251.5001.6301.4851.620227.5K
23 Oct 251.5901.5901.4701.500115.8K
22 Oct 251.6001.6801.4401.580380.2K
21 Oct 251.2901.6501.2301.6401.23M

COMPANY PROFILE

Name:Prelude Therapeutics Inc
About:Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Sector:Healthcare
Industry:Biotechnology
Address:175 Innovation Boulevard, Wilmington, DE, United States, 19805
Website:https://preludetx.com
CUSIP:74065P101
CIK:0001678660
ISIN:US74065P1012
FIGI:BBG00K7JY2Q6

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.37 
Forward P/E:-1.05 
PEG Ratio:0.22 
Price to Sales:12.86 
Price to Book:1.60 
Operating Margin:-19.29 
Return on Assets:-0.50 
Return on Equity:-0.96 
EPS Ratio:-1.64 
Revenue:7.0M 
Shares:43.75M 
Market Cap:174.13M 

TECHNICAL INDICATORS

MA5:2.0594.0%
MA10:1.83117.4%
MA20:1.58152.5%
MA50:1.37190.8%
MA100:1.12255.3%
MA200:1.00299.6%
STO9:91.18 
STO14:92.08 
RSI14:86.61 
MTM14:2.62
ROC14:1.93 
ATR:0.36 
Week High:4.226.0%
Week Low:1.43178.3%
Month High:4.226.0%
Month Low:1.15299.6%
Year High:4.226.0%
Year Low:0.61552.4%
Volatility:30.45